OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds
Thomas Wilke, Nils Picker, Sabrina Müller, et al.
ClinicoEconomics and Outcomes Research (2022) Vol. Volume 14, pp. 319-332
Open Access | Times Cited: 6
Thomas Wilke, Nils Picker, Sabrina Müller, et al.
ClinicoEconomics and Outcomes Research (2022) Vol. Volume 14, pp. 319-332
Open Access | Times Cited: 6
Showing 6 citing articles:
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature Review
Khalid M Hamed, Mohammed N Alosaimi, Bashaer A Ali, et al.
Cureus (2024)
Open Access | Times Cited: 7
Khalid M Hamed, Mohammed N Alosaimi, Bashaer A Ali, et al.
Cureus (2024)
Open Access | Times Cited: 7
Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes
Phyo T. Htoo, Mehdi Najafzadeh, Helen Tesfaye, et al.
Diabetes Care (2024) Vol. 47, Iss. 11, pp. 1900-1907
Open Access | Times Cited: 1
Phyo T. Htoo, Mehdi Najafzadeh, Helen Tesfaye, et al.
Diabetes Care (2024) Vol. 47, Iss. 11, pp. 1900-1907
Open Access | Times Cited: 1
Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark
Reimar W. Thomsen, Lotte W. B. Christensen, Johnny Kahlert, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 11-12, pp. 1891-1906
Open Access | Times Cited: 4
Reimar W. Thomsen, Lotte W. B. Christensen, Johnny Kahlert, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 11-12, pp. 1891-1906
Open Access | Times Cited: 4
Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease
Shuyao Zhang, F N U Sidra, Carlos A. Álvarez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Shuyao Zhang, F N U Sidra, Carlos A. Álvarez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Qual é a eficácia da associação de fosfato de sitagliptina e cloridrato de metformina em comparação com o uso isolado de cloridrato metformina em adultos portadores de diabetes mellitus tipo 2 insulino-independentes?
International Journal of Development Research (2022), pp. 59555-59560
Open Access
International Journal of Development Research (2022), pp. 59555-59560
Open Access
Vergleich der Gesundheitskosten von Typ-2 Diabetikern bei der Anwendung von Empagliflozin, DPP-4-Hemmern und GLP-1-Agonisten (Print)
et al. Wilke
Monitor Versorgungsforschung (2022) Vol. 15, Iss. 06/2022
Open Access
et al. Wilke
Monitor Versorgungsforschung (2022) Vol. 15, Iss. 06/2022
Open Access
